The group’s principle activity is to provide solutions for the treatment of vascular disease. The group’s products include carotid stent systems, cobalt chromium coronary stent platforms, rapid exchange technology, balloon dilatation catheters, guide wires, and vessel closure technologies. The group operates from United States.
